LA
IDXX icon

Leonetti & Associates’s Idexx Laboratories IDXX Stock Holding History

Leonetti & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-60,220
Closed -$15M – 35
2018
Q3 		$15M Buy
60,220
+950
+2% +$231K 3.85% 6
2018
Q2 		$12.9M Buy
59,270
+2,295
+4% +$473K 3.51% 8
2018
Q1 		$10.9M Buy
+56,975
New +$10.5M 3.16% 9

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Leonetti & Associates's IDXX Position: Q4 2018 in Review

Leonetti & Associates sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 60,220 shares — an estimated $15M sold.

Leonetti & Associates first reported a position in IDXX in Q1 2018 and held it in 3 quarters. The position peaked at $15M in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

  • Leonetti & Associates reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
  • Leonetti & Associates sold 60,220 Idexx Laboratories shares in Q4 2018, an estimated $15M.
  • Leonetti & Associates first reported a position in Idexx Laboratories in Q1 2018 and held it in 3 quarters.
  • Leonetti & Associates's Idexx Laboratories position peaked at $15M in Q3 2018.
  • 670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Leonetti & Associates's 13F filing for Q4 2018, filed 19 Feb 2019.